Annual Report | Alnylam® Newsroom

Global English
- AustriaDeutsch
- BelgiumNederlands Français
- BrazilPortuguês
- CanadaFrançais English
- Czech RepublicČeština
- DenmarkDansk
- FranceFrançais
- GermanyDeutsch
- IrelandEnglish
- ItalyItaliano
- Japan日本語
- LuxembourgFrançais Deutsch
- NetherlandsNederlands
- PortugalPortuguês
- SpainEspañol
- SwedenSvenska
- SwitzerlandFrançais Deutsch Italiano
- Taiwan繁體中文
- United KingdomEnglish

Annual Report

April 2, 2024 2023 Year in Review: CEO Yvonne Greenstreet Reflects on a Year of Substantial Growth and P ... Alnylam CEO Yvonne Greenstreet reflects on the company's accomplishments in 2023 and highlights of the 2023 annual report. Read More ›

April 24, 2023 2022 Annual Report: CEO Yvonne Greenstreet Reflects on the Next Chapter in the RNAi Revolu ... Alnylam CEO Yvonne Greenstreet reflects on the company's accomplishments in 2022 and highlights of the 2022 annual report. Read More ›

April 15, 2022 2021 Annual Report: CEO Yvonne Greenstreet Reflects on an Important Year in the RNAi Revol ... In conjunction with the publishing of Alnylam's 2021 Annual Report, Alnylam's CEO Yvonne Greenstreet reflects on the year that was... Read More ›

Subscribe to Annual Report

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site